These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 30359884)

  • 21. A matrix dispersion based on phospholipid complex system: preparation, lymphatic transport, and pharmacokinetics.
    Li H; Lu S; Luo M; Li X; Liu S; Zhang T
    Drug Dev Ind Pharm; 2020 Apr; 46(4):557-565. PubMed ID: 32126844
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new function of Vitamin E-TPGS in the intestinal lymphatic transport of lipophilic drugs: enhancing the secretion of chylomicrons.
    Fan Z; Wu J; Fang X; Sha X
    Int J Pharm; 2013 Mar; 445(1-2):141-7. PubMed ID: 23396256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bioavailability enhancement, Caco-2 cells uptake and intestinal transport of orally administered lopinavir-loaded PLGA nanoparticles.
    Joshi G; Kumar A; Sawant K
    Drug Deliv; 2016 Nov; 23(9):3492-3504. PubMed ID: 27297453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile salt integrated cerasomes: A potential nanocarrier for enhancement of the oral bioavailability of idarubicin hydrochloride.
    Emzhik M; Haeri A; Javidi J; Abdollahizad E; Qaribnejad A; Rezaee E; Torshabi M; Dadashzadeh S
    Int J Pharm; 2024 Sep; 662():124518. PubMed ID: 39074645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of chylomicron uptake into lacteals.
    Dixon JB
    Ann N Y Acad Sci; 2010 Oct; 1207 Suppl 1(Suppl 1):E52-7. PubMed ID: 20961306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regorafenib loaded self-assembled lipid-based nanocarrier for colorectal cancer treatment via lymphatic absorption.
    Xia D; Hu C; Hou Y
    Eur J Pharm Biopharm; 2023 Apr; 185():165-176. PubMed ID: 36870399
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validity of cycloheximide chylomicron flow blocking method for the evaluation of lymphatic transport of drugs.
    Ryšánek P; Grus T; Lukáč P; Kozlík P; Křížek T; Pozniak J; Roušarová J; Královičová J; Kutinová Canová N; Boleslavská T; Bosák J; Štěpánek F; Šíma M; Slanař O
    Br J Pharmacol; 2021 Dec; 178(23):4663-4674. PubMed ID: 34365639
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intestinal transport as a potential determinant of drug bioavailability.
    Nauli AM; Nauli SM
    Curr Clin Pharmacol; 2013 Aug; 8(3):247-55. PubMed ID: 23343017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA.
    Li Z; Zhang Y; Zhang K; Wu Z; Feng N
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):578-587. PubMed ID: 29374971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose-Based Mesoporous Carbon Nanospheres as Functional Carriers for Oral Delivery of Amphiphobic Raloxifene: Insights into the Bioavailability Enhancement and Lymphatic Transport.
    Ye Y; Zhang T; Li W; Sun H; Lu D; Wu B; Zhang X
    Pharm Res; 2016 Mar; 33(3):792-803. PubMed ID: 26553355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
    Li T; Geng T; Md A; Banerjee P; Wang B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural sesame oil is superior to pre-digested lipid formulations and purified triglycerides in promoting the intestinal lymphatic transport and systemic bioavailability of cannabidiol.
    Feng W; Qin C; Chu Y; Berton M; Lee JB; Zgair A; Bettonte S; Stocks MJ; Constantinescu CS; Barrett DA; Fischer PM; Gershkovich P
    Eur J Pharm Biopharm; 2021 May; 162():43-49. PubMed ID: 33677067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uptake of lipophilic drugs by plasma derived isolated chylomicrons: linear correlation with intestinal lymphatic bioavailability.
    Gershkovich P; Hoffman A
    Eur J Pharm Sci; 2005 Dec; 26(5):394-404. PubMed ID: 16140514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: dexanabinol and PRS-211,220.
    Gershkovich P; Qadri B; Yacovan A; Amselem S; Hoffman A
    Eur J Pharm Sci; 2007 Aug; 31(5):298-305. PubMed ID: 17560096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a chylomicron flow blocking approach to investigate the intestinal lymphatic transport of lipophilic drugs.
    Dahan A; Hoffman A
    Eur J Pharm Sci; 2005 Mar; 24(4):381-8. PubMed ID: 15734305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of surface modification and size on oral drug delivery of mesoporous silica formulation.
    Wang Y; Cui Y; Zhao Y; Zhao Q; He B; Zhang Q; Wang S
    J Colloid Interface Sci; 2018 Mar; 513():736-747. PubMed ID: 29220688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intestinal lymphatic transport of halofantrine in rats assessed using a chylomicron flow blocking approach: the influence of polysorbate 60 and 80.
    Lind ML; Jacobsen J; Holm R; Müllertz A
    Eur J Pharm Sci; 2008 Oct; 35(3):211-8. PubMed ID: 18675904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The oral absorption of phospholipid prodrugs: in vivo and in vitro mechanistic investigation of trafficking of a lecithin-valproic acid conjugate following oral administration.
    Dahan A; Duvdevani R; Shapiro I; Elmann A; Finkelstein E; Hoffman A
    J Control Release; 2008 Feb; 126(1):1-9. PubMed ID: 18082281
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment.
    Patel G; Shelat P; Lalwani A
    Drug Deliv; 2016 Oct; 23(8):3027-3042. PubMed ID: 26882014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights on Oral Drug Delivery of Lipid Nanocarriers: a Win-Win Solution for Augmenting Bioavailability of Antiretroviral Drugs.
    Nabi B; Rehman S; Baboota S; Ali J
    AAPS PharmSciTech; 2019 Jan; 20(2):60. PubMed ID: 30623263
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.